High Serum Levels of TGF-β in Iranians With Chronic HBV Infection

Hepatitis Monthly

Volumn 12, Issue 11, 2012, Pages

  Khorramdelazad, Hossein ^a   Hassanshahi, Gholamhossein ^a   Ahmadabadi, Behzad Nasiri ^a   Arababadi, Mohammad Kazemi ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B, Chronic; Transforming Growth Factor Beta

Indexed keywords

EID: 84897890375     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.7581     Document Type: Article

References (19)

1. Assar S, Arababadi MK, Mohit M, Ahmadabadi BN, Pumpens P, Khorramdelazad H, et al. T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infec-tion: a study from the South-Eastern region of Iran. Clin Lab. 2012;58(1-2):53-60.
2. Ahn SH, Kim do Y, Chang HY, Hong SP, Shin JS, Kim YS, et al. As-sociation of genetic variations in CCR5 and its ligand, RAN-TES with clearance of hepatitis B virus in Korea. J Med Virol. 2006;78(12):1564-71.
3. Ahmadabadi BN, Hassanshahi G, Arababadi MK, Leanza C, Kennedy D. The IL-10 promoter polymorphism at position-592 is cor-related with susceptibility to occult HBV infection. Inflammation. 2012;35(3):818-21.
4. Zhou J, Huang Y, Tian D, Xu D, Chen M, Wu H. Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads. J Huazhong Univ Sci Technolog Med Sci. 2009;29(3):313-7.
5. Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G. Serum Levels of IL-10 and IL-17A in Occult HBV-Infected South-East Iranian Patients. Hepat Mon. 2010;10(1):31-5.
6. Regateiro FS, Howie D, Cobbold SP, Waldmann H. TGF-beta in transplantation tolerance. Curr Opin Immunol. 2011;23(5):660-9.
7. Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, et al. TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012;8(3):e1002594.
8. Liu HG, Chen WW, Fan ZP, Yang HY, Shi M, Zhang Z, et al. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. Clin Immunol. 2007;125(3):337-45.
9. Arababadi MK, Nasiri Ahmadabadi B, Kennedy D. Current infor-mation on the immunologic status of occult hepatitis B infec-tion. Transfusion. 2012;52(8):1819-26.
10. Divella R, Daniele A, Gadaleta C, Tufaro A, Venneri MT, Paradiso A, et al. Circulating transforming growth factor-beta and epidermal growth factor receptor as related to virus infection in liver carcinogenesis. Anticancer Res. 2012;32(1):141-5.
11. El-Tayeh SF, Hussein TD, El-Houseini ME, Amer MA, El-Sherbini M, Elshemey WM. Serological biomarkers of hepatocellular carcinoma in Egyptian patients. Dis Markers. 2012;32(4):255-63.
12. Guo JC, Bao JF, Chen QW, Li XO, Shi JP, Lou GQ, et al. [Level of serum and liver tissue TGF-beta1 in patients with liver fibrosis due to chronic hepatitis B]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008;22(5):354-7.
13. Lebensztejn DM, Sobaniec-Lotowska M, Kaczmarski M, Werpachows-ka I, Sienkiewicz J. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B. Hepatogastroenterology. 2004;51(55):229-33.
14. Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M. Rela-tionship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J Gastroenterol. 2005;11(21):3260-3.
15. Yu SK, Kwon OS, Jung HS, Bae KS, Kwon KA, Kim YK, et al. Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers. J Korean Med Sci. 2010;25(4):564-9.
16. Mondelli MU, Varchetta S, Oliviero B. Natural killer cells in viral hepa-titis: facts and controversies. Eur J Clin Invest. 2010;40(9):851-63.
17. Bertoletti A, Maini MK, Ferrari C. The host-pathogen interaction during HBV infection: immunological controversies. Antivir Ther. 2010;15 (Suppl 3):15-24.
18. McMahon BJ. The natural history of chronic hepatitis B virus infec-tion. Hepatology. 2009;49(5 Suppl):S45-55.
19. Li J, Wu W, Peng G, Chen F, Bai M, Zheng M, et al. HBcAg induces inter-leukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol. 2010;88(8):834-41.